Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
86.55
+1.05 (1.23%)
At close: May 11, 2026, 4:00 PM EDT
86.55
0.00 (0.00%)
After-hours: May 11, 2026, 6:25 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $836.91 million as of May 11, 2026. Its market cap has increased by 294.85% in one year.
Market Cap
836.91M
Enterprise Value
771.83M
1-Year Change
294.85%
Ranking
Category
Stock Price
$86.55
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $836.91M, an increase of 1,902.98%. That is a compound annual growth rate of 77.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 804.32M | 28.25% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 854.72M |
| Seaport Therapeutics | 851.10M |
| Alto Neuroscience | 850.38M |
| Lexicon Pharmaceuticals | 847.36M |
| Kura Oncology | 836.14M |
| Evommune | 825.54M |
| Allogene Therapeutics | 784.27M |
| SpyGlass Pharma | 782.52M |